4,943 Shares in Syneos Health, Inc. (NASDAQ:SYNH) Acquired by Somerset Trust Co

Somerset Trust Co purchased a new position in Syneos Health, Inc. (NASDAQ:SYNH) during the second quarter, Holdings Channel reports. The fund purchased 4,943 shares of the company’s stock, valued at approximately $208,000.

Other institutional investors have also recently made changes to their positions in the company. Russell Investments Group Ltd. increased its holdings in shares of Syneos Health by 225.7% in the 1st quarter. Russell Investments Group Ltd. now owns 946,932 shares of the company’s stock worth $33,730,000 after buying an additional 656,172 shares during the last quarter. Schroder Investment Management Group increased its stake in Syneos Health by 20.1% during the 4th quarter. Schroder Investment Management Group now owns 665,336 shares of the company’s stock valued at $24,405,000 after purchasing an additional 111,568 shares in the last quarter. Harbor Investment Advisory LLC increased its stake in Syneos Health by 87.0% during the 1st quarter. Harbor Investment Advisory LLC now owns 3,112 shares of the company’s stock valued at $111,000 after purchasing an additional 1,448 shares in the last quarter. Farallon Capital Management LLC bought a new stake in Syneos Health during the 1st quarter valued at about $16,813,000. Finally, Beverly Hills Private Wealth LLC bought a new stake in Syneos Health during the 4th quarter valued at about $217,000. Institutional investors own 91.16% of the company’s stock.

Syneos Health Stock Performance

Shares of SYNH traded up $0.01 on Friday, reaching $42.78. The company’s stock had a trading volume of 72,996 shares, compared to its average volume of 1,899,295. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.20 and a quick ratio of 1.20. The stock has a market capitalization of $4.44 billion, a P/E ratio of 61.99 and a beta of 1.58. The stock’s 50 day simple moving average is $42.52 and its two-hundred day simple moving average is $40.48. Syneos Health, Inc. has a 12-month low of $22.89 and a 12-month high of $52.23.

Syneos Health (NASDAQ:SYNH) last posted its quarterly earnings data on Tuesday, August 8th. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.64 by ($0.63). Syneos Health had a return on equity of 8.63% and a net margin of 1.31%. The business had revenue of $1.37 billion during the quarter, compared to analysts’ expectations of $1.26 billion. Research analysts forecast that Syneos Health, Inc. will post 2.79 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on shares of Syneos Health in a research note on Friday. They set a “hold” rating for the company. Seven investment analysts have rated the stock with a hold rating, According to data from MarketBeat, Syneos Health has a consensus rating of “Hold” and an average price target of $40.00.

Syneos Health Profile

Syneos Health, Inc, operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development.